nor-NOHA
- Generic Name
- nor-NOHA
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C5H12N4O3
- CAS Number
- 189302-40-7
- Unique Ingredient Identifier
- U0F1149OFR
- Background
N-Hydroxy-nor-L-arginine (nor-NOHA) is under investigation in clinical trial NCT02009527 (Arginase Inhibition in Ischemia-reperfusion Injury).
- Associated Conditions
- -
- Associated Therapies
- -
Arginase Inhibition in Ischemia-reperfusion Injury
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2013-12-12
- Last Posted Date
- 2015-04-20
- Lead Sponsor
- Karolinska Institutet
- Target Recruit Count
- 24
- Registration Number
- NCT02009527
- Locations
- 🇸🇪
Karolinska Institutet, Stockholm, Sweden
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath